Skip to main content
Clinical Trials/ISRCTN14163439
ISRCTN14163439
Completed
未知

Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial)

niversity of Birmingham0 sites4,153 target enrollmentFebruary 11, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Topic: Reproductive health and childbirth
Sponsor
niversity of Birmingham
Enrollment
4153
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31067371 [added 09/05/2019] 2020 cost-effectiveness analysis in https://www.ncbi.nlm.nih.gov/pubmed/32003141(03/02/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32609084/ (added 02/07/2020)

Registry
who.int
Start Date
February 11, 2015
End Date
June 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Correct as of 01/02/2017
  • 1\. Women presenting with with early pregnancy vaginal bleeding that has occurred within the last 4 days and is in the first 12 weeks of pregnancy
  • 2\. Upper Age Limit 39 years
  • 3\. Lower Age Limit 18 years
  • Previous inclusion criterion:
  • 1\. Women presenting with vaginal bleeding in the first 12 weeks of pregnancy with an intrauterine gestation sac visible on ultrasonography

Exclusion Criteria

  • 1\. Women of age less than 18 years or more than 40
  • 2\. Women with life\-threatening bleeding
  • 3\. Women already taking progesterone supplementation therapy
  • 4\. Women with contraindications to progesterone use

Outcomes

Primary Outcomes

Not specified

Similar Trials